Ranjit Swain

Dr. Ranjit Swain

Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2024 in ACS Omega
Verified
Journal Article
Open access
RSRanjit Swain
Ranjit Swain
GOgamal osman
gamal osman
ABAbhishek Bhattacharjee
Abhishek Bhattacharjee
RSRam Kumar Sahu
Ram Kumar Sahu
JKJiyauddin Khan
Jiyauddin Khan
In the current study, it was intended to prepare liquisolid tablets of pioglitazone HCl to improve the bioavailability and dissolution time of the drug, as it has low solubility in water. Mathematical formulas were adopted, and the quantities of the carrier (MCC), coating material (colloidal silicon dioxides), and nonvolatile liquid vehicle (Tween 80) were taken. Various ratios of the drug to liquid and carrier to coating had been used in the formulation of liquisolid compacts. The evaluation of the formulated liquisolid compacts was done by performing FTIR, DSC, XRD, and SEM studies. Postcompression parameters, dissolution, stability, and bioavailability were accessed for the optimized formulation. FTIR and DSC studies showed the compatibility of the drugs and excipients. XRD revealed the transition to the amorphous state. It was found that the properties of the newly manufactured liquisolid tablets were within the parameters of what is considered acceptable. The optimized formulation of LST10 showed 99.87 +/- 0.19% (p < 0.05) pioglitazone released within 60 min of dissolution. Dissolution data treatments (Q(15), IDR, RDR, %DE, MDT, f(1), and f(2)) resulted in better drug release than other drugs studied and marketed tablet formulations. The optimized formulation produced had been proven stable when it was subjected to accelerated stability testing. This suggested that the bioavailability of pioglitazone was enhanced, as indicated by the substantial increase in AUC(0-t) (3.06-fold) and C-max (4.18-fold). According to the findings, the selected combination and method significantly increased the dissolution time and bioavailability of pioglitazone. Moreover, this developed method can be used for other drugs with low water solubility.

24 November 2022 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
NSNigama Chandra Sattenapalli
Nigama Chandra Sattenapalli
RSRanjit Swain
Ranjit Swain
SGSiva Naga Koteswara Rao Gudhanti
Siva Naga Koteswara Rao Gudhanti
The main purpose of the present review is to compile the recent information with special focus on different aspects of muscular dystrophy. Muscular dystrophies are the group of genetic disorders that causes progressive muscle weakness and degeneration of skeletal muscles, restricts their movement and functions, and is irreversible. There is no clear picture and statistics on muscular dystrophy effected individuals especially in India. This article specifies and acknowledges the muscular dystrophy facts and particulars all over the world especially focusing the story in India. The study is based on statistics taken from several reports gathered by different organizations in India, as well as, from other data sources published. In this regard, this present review highlighted the areas of epidemiology, present scenario of prevalence, types of muscular dystrophy specially focused on genetic involment, identification of clinical symptoms, clinical diagnosis specially focused in India, care, management and treatment of this disorder.

28 June 2019 in INDIAN DRUGS
Verified
Journal Article
Closed access
SSS. M. Sai
S. M. Sai
RSRanjit Swain
Ranjit Swain
AMA. K Mahapatra
A. K Mahapatra
The objective of the present investigation was to evaluate the entrapment efficiency of the anti-HIV drug, zidovudine, using natural gums and study the zidovudine release. Zidovudine-loaded microspheres were prepared by external ionotropic gelation technique. Sodium alginate in combination with guar gum or xanthan gums in different ratios were used. The microspheres of different core: coat ratios were formulated and evaluated for entrapment efficiency, particle size, percentage yield, swelling index, in vitro drug release and kinetic studies. Drug polymer compatibility studies were performed by Fourier Transform Infrared (FTIR) spectroscopy. The formulation was characterized by X-ray powder diffraction (XRD) and scanning electron Microscope (SEM). The zidovudine loaded microspheres have a particle diameter ranging approximately 450-779 μm. The FTIR showed compatibility between drug and excipients. Processing parameters (stirring speed, concentration of cross linking agent, volume of the processing medium on drug entrapment efficiency were optimized. F20 (1 g of sodium alginate and 0.150 g of guar gum) and F13 (1 g of sodium alginate, 0.250 g of xanthan gum) formulations showed better release (ANOVA, ˂0.05) profiles over a period of 12 h. Natural gums are biodegradable, safe, non-toxic and are used as release retardants and these can be extended to prepare microspheres of other drugs.